News

Article

Pharmaceutical Technology Europe

Pharmaceutical Technology Europe

Pharmaceutical Technology Europe-04-01-2005
Volume17
Issue 4

Ion Exchange Resinates — The Technology Behind the Mystery

Author(s):

Lyn Hughes, PhD

In this article, the author explains some of the technology behind using ion-exchange resins for drug delivery...

External Link - article-154312.pdf

Articles in this issue
Nanotechnology Applications for Drug Delivery
Nanotech Not Big Enough for Pharma?
Protecting Intellectual Property Prior to Commercialization
Nanostructured Lipid Carriers: A Novel Generation of Solid Lipid Drug Carriers
Ion Exchange Resinates — The Technology Behind the Mystery
Maintaining the Safety of EU Drugs
Defining The Borders
The Effect of Core Design and Formulation on the Quality of Film Coated Tablets

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content
White House | Image Credit: © Zack Frank - stock.adobe.com
August 3rd 2025

Trump Sends Letters to 17 Leading Pharma Companies Outlining Most-Favored-Nation Drug Pricing Protocol

Patrick Lavery
If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 3rd 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
automatic stainless steel pharmaceutical fermenter | Image Credit: ©gen_A - stock.adobe.com
August 3rd 2025

In-line UV Spectrometry Monitoring in Cleaning Validation

John Schallom Brian Bosso Paul Lopolito Katie Frey Amy Thanavaro
The authors performed interference and enhancement testing using a formulated alkaline and acid cleaner, as well as common biopharmaceutical process residues.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
August 3rd 2025

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com
August 3rd 2025

EMA Encourages Use of New Approach Methodologies to Reduce Animal Testing

Cheryl Barton
EMA is phasing out animal testing and is asking pharmaceutical companies to use new approach methodologies.
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 3rd 2025

GSK and Hengrui Pharma Collaborate on Drug Development

Susan Haigney
The two companies have entered into an agreement to develop respiratory, immunology, inflammation, and cancer therapies.